CPC A61N 1/36139 (2013.01) [A61B 5/245 (2021.01); A61B 5/291 (2021.01); A61B 5/369 (2021.01); A61B 5/377 (2021.01); A61B 5/4824 (2013.01); A61B 5/4836 (2013.01); A61N 1/36071 (2013.01); A61N 1/36185 (2013.01); A61B 5/4848 (2013.01); A61N 1/0534 (2013.01); A61N 1/0551 (2013.01); A61N 1/36062 (2017.08)] | 20 Claims |
1. A method of providing neuromodulation to a patient via a medical-device system, the method comprising:
receiving brain activity signals sensed from the patient in response to neuromodulation delivered in accordance with respective candidate therapy settings;
calculating a brain activity score from each of the received brain activity signals;
selecting a therapy setting from the candidate therapy settings based at least in part on the calculated brain activity scores, the selected therapy setting including a distribution of neuromodulation energy over multiple neuromodulation sites; and
initiating or adjusting a neuromodulation therapy in accordance with the selected therapy setting.
|